{"summary":"Senior Scientist with broad experience in antibody discovery, engineering and characterization.","lastName":"Fitzgerald","objectUrn":"urn:li:member:29237692","geoRegion":"Greater Boston","fullName":"Kyle Fitzgerald","firstName":"Kyle","currentPositions":[{"companyName":"Mythic Therapeutics, Inc.","title":"Associate Director","tenureAtCompany":{"numMonths":3},"companyUrnResolutionResult":{"employeeCountRange":"11-50","headquarters":{"geographicArea":"Massachusetts","country":"United States","city":"Waltham","postalCode":"02453","line1":"100 Beaver St"},"website":"http:\/\/www.mythictx.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/mythic-therapeutics\/","industry":"Biotechnology Research"},"startedOn":{"month":3,"year":2024},"companyUrn":"urn:li:fs_salesCompany:27133031"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAG-IbwBRFaEl5lfoua90anaz3L1xbxatF0,NAME_SEARCH,_Kb5)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1634328212783?e=1723075200&v=beta&t=T1SAbEpS5XEoEL6rwB3dUvYb1pQa1OpTLZVuPTtRgiU","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1634328212783?e=1723075200&v=beta&t=-j6yUTbxiQ5PodrWqwwCJ397fzzOeGFPkqBXVGqiiAo","height":200},{"width":260,"fileIdentifyingUrlPathSegment":"400_400\/0\/1634328212783?e=1723075200&v=beta&t=UOiagbSBarPGeNZjeb4Symhk5cRRy9MBGRwdSBXgHpY","height":260},{"width":260,"fileIdentifyingUrlPathSegment":"800_800\/0\/1634328212783?e=1723075200&v=beta&t=g3__moJlbDBYoCjsT0rTbE-ob5JlcXswOmjr6uZBia0","height":260}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E03AQHMx_Ms4Kjn_Q\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2009},"degree":"BS","eduId":24128268,"schoolUrn":"urn:li:fs_salesSchool:8706","school":"urn:li:fs_salesSchool:8706","fieldsOfStudy":["Biological Sciences"],"startedOn":{"year":2005}},{"endedOn":{"year":2013},"degree":"MS","eduId":87067642,"schoolUrn":"urn:li:fs_salesSchool:165631","school":"urn:li:fs_salesSchool:165631","fieldsOfStudy":["Molecular and Cell Biology"],"schoolName":"Quinnipiac University","startedOn":{"year":2010}},{"degree":"CORe: Curriculum of Readiness","schoolUrn":"urn:li:fs_salesSchool:9220773","eduId":350995038,"school":"urn:li:fs_salesSchool:9220773","schoolName":"HBX \/ Harvard Business School","startedOn":{"year":2015}}],"skills":[{"numOfEndorsement":10,"name":"Protein Purification"},{"numOfEndorsement":12,"name":"Assay Development"},{"numOfEndorsement":9,"name":"PCR"},{"numOfEndorsement":8,"name":"Protein Chemistry"},{"numOfEndorsement":10,"name":"ELISA"},{"numOfEndorsement":7,"name":"Molecular Biology"},{"numOfEndorsement":7,"name":"Protein Expression"},{"numOfEndorsement":3,"name":"Laboratory Automation"},{"numOfEndorsement":2,"name":"Phage Display"},{"numOfEndorsement":4,"name":"High Throughput Screening"},{"numOfEndorsement":4,"name":"Western Blotting"},{"numOfEndorsement":1,"name":"DNA sequencing"},{"numOfEndorsement":1,"name":"Protein-protein Interactions"},{"numOfEndorsement":1,"name":"Purification"},{"numOfEndorsement":2,"name":"SDS-PAGE"},{"numOfEndorsement":2,"name":"Cell Biology"},{"numOfEndorsement":3,"name":"DNA"},{"numOfEndorsement":2,"name":"Gel Electrophoresis"},{"numOfEndorsement":3,"name":"Polymerase Chain Reaction (PCR)"},{"numOfEndorsement":0,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":0,"name":"Protein Conjugation"},{"numOfEndorsement":0,"name":"SPR"},{"numOfEndorsement":1,"name":"DNA Sequencing"}],"numOfConnections":663,"patents":[],"headline":"Developing the next generation of ADC therapies","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/kfitzg","organizations":[],"location":"Greater Boston","publications":[{"publishedOn":{"month":3,"day":4,"year":2024},"description":"ABSTRACT\nBiparatopic antibodies (bpAbs) bind distinct, non-overlapping epitopes on an antigen. This unique binding mode enables new mechanisms of action beyond monospecific and bispecific antibodies (bsAbs) that can make bpAbs effective therapeutics for various indications, including oncology and infectious diseases. Biparatopic binding can lead to superior affinity and specificity, promote antagonism, lock target conformation, and result in higher-order target clustering. Such antibody-target complexes can elicit strong agonism, increase immune effector function, or result in rapid target downregulation and lysosomal trafficking. These are not only attractive properties for therapeutic antibodies but are increasingly being explored for other modalities such as antibody-drug conjugates, T-cell engagers and chimeric antigen receptors. Recent advances in bpAb engineering have enabled the construction of ever more sophisticated formats that are starting to show promise in the clinic.","url":"https:\/\/doi.org\/10.1080\/19420862.2024.2310890","name":"Biparatopic antibodies: therapeutic applications and prospects","publisher":"mAbs","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAG-IbwBRFaEl5lfoua90anaz3L1xbxatF0,NAME_SEARCH,_Kb5)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABiSDbkBTFFmumpp2ubygki2DbKZIrEq2UQ,NAME_SEARCH,lDjE)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAALOehIBMOIIUPM0ta10MvAOBVC21bSbR0A,NAME_SEARCH,fLI_)"}]}],"positions":null,"posts":[{"createdAt":1714182120000,"insightId":"c0144d72-d0b1-4544-aef5-326d714d0a61","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":7},{"type":"PRAISE","count":1},{"type":"EMPATHY","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7189801158742351872","threadUrn":"urn:li:activity:7189801158742351872","reactionsCount":11,"commentsCount":2,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7189801158264172545","message":{"attributes":[{"start":0,"length":5,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:77189953"}}}],"text":"Apoha sweatshirt keeping my warm on a brisk spring day"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQGXkDoumu7SNw\/feedshare-shrink_2048_1536\/0\/1714160739031?e=1720051200&v=beta&t=pf87GZM7cXL1YPvTxxdy4PnPU2W3ZASTMTB6PpY85YE"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7189711245229400064","message":{"attributes":[{"start":65,"length":16,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:2062124"}}},{"start":307,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:mythicproud"}}}],"text":"Yesterday, a cohort of Mythic employees celebrated Earth Week at The Food Project's Baker Bridge Farm in Lincoln.\u00a0Our visit consisted of weeding the garlic bed and planting over 2000 onions! We at Mythic\u00a0are grateful to have the opportunity to give back to our local community and support a great cause.\u00a0\n\u00a0\n#MythicProud"},"entityUrn":"urn:li:share:7189711245229400064"},"entityUrn":"urn:li:share:7189801158264172545"}}},{"createdAt":1712350260000,"insightId":"a359f176-86a8-45cf-ae96-46e8df1f40c0","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":11}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7182117794115649536","threadUrn":"urn:li:activity:7182117794115649536","reactionsCount":11,"commentsCount":1,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7182117793721397248","message":{"attributes":[],"text":"If anyone in my network is in San Diego let me know! I\u2019ll be at AACR supporting my colleagues and learning from scientists around the world."},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D5622AQEraXSudJlJcQ\/feedshare-shrink_2048_1536\/0\/1712201951776?e=1720051200&v=beta&t=9q0KG7UwVMCTKcdfyHfJprEBv4evbDAQ5bQW5Ml8BqY"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7181495496723636225","message":{"attributes":[{"start":11,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:aacr24"}}},{"start":118,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:adc"}}},{"start":217,"length":14,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"http:\/\/bit.ly\/3TxrVrR"}}}],"text":"Heading to #AACR24 next week? Don\u2019t miss our presentation of preclinical data from our investigational cMET-targeting\u202f#ADC, MYTX-011, taking place on April 8. \n\nSee more details below and view our full abstract here: bit.ly\/3TxrVrR\u00a0"},"entityUrn":"urn:li:share:7181495496723636225"},"entityUrn":"urn:li:share:7182117793721397248"}}}]}